Skip to main content
OpenTrials
Completed

NCT Number: NCT00882453

Physical Activity and Fatigue in Early Multiple Sclerosis (MS)

The purpose of this observational study is to obtain a survey on physical activity in patients who for the first time have experienced symptoms which indicate a high risk for developing multiple sclerosis (MS) and in patients with recently diagnosed MS, and to obtain information on factors potentially influencing the patients' level of activity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Many Locations, Australia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Multiple sclerosis diagnosed within the last 12 months
  • Clinically isolated Syndrome (CIS), under Interferon-beta-1b treatment

Treatment and study plan

Interferon beta-1b (Betaseron, BAY86-5046)

Drug

Intravenous therapy according to product information

Primary outcomes

  1. Physical Activity and Fatigue

    Time frame: At baseline and at Month 24

Secondary outcomes

  1. Health-related Quality of Life

    Time frame: At baseline and at Month 24

  2. Depression

    Time frame: At baseline and at Month 24

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

Betaferon Treatment and Exercise Data Gathering IN Early MS

Acronym: BEGIN

Important dates

Study start
2006
Primary completion
2011
Study completion
2011
First posted
Apr 16, 2009
Registry last updated
May 30, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.